InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,882.80
(
0.45%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.50
(
-0.12%
)
Bitcoin
63,007.74
(
3.66%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Kag

Send PM Follow Ignore
Followers 1
Posts 788
Boards Moderated 0
Alias Born 02/01/2006

Kag

Re: opportunityknocking post# 16720

Thursday, 10/09/2008 9:24:28 AM

Thursday, October 09, 2008 9:24:28 AM

Post# of 30387
Opportunity Knocking,
My first concern would be who performed the testing? Was it BioCurex? My second concern would be to notice that the cutoff units of RECAF varied considerably with the different cancer types. RECAF does not have the ability to tell what kind of cancer it is. How is a technician in a lab going to know what to set the RECAF cutoff units at if the type of cancer is unknown? kag
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up